Prime Medicine, Inc.
PRME
$3.69
$0.13883.91%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.35% | -22.74% | 19.50% | 5.08% | -20.90% |
| Total Depreciation and Amortization | 9.65% | -0.99% | 10.21% | 1.30% | 16.96% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -2.44% | 13.12% | -0.35% | -38.90% | 90.47% |
| Change in Net Operating Assets | 107.16% | -115.66% | 186.13% | 459.57% | 84.23% |
| Cash from Operations | 15.24% | -400.75% | 162.69% | 43.04% | 32.81% |
| Capital Expenditure | 35.09% | -35.23% | -40.25% | 32.86% | 18.16% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 109.58% | -190.56% | -3.05% | 486.85% | 125.34% |
| Cash from Investing | 105.80% | -198.94% | -4.15% | 630.23% | 118.62% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -100.00% | 109,937.14% | -99.97% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -100.00% | -- | -- | -- | -100.00% |
| Cash from Financing | -96.72% | 599,900.00% | -100.00% | 109,937.14% | -99.98% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 57.57% | -240.47% | 2.47% | 263.23% | -173.33% |